Intimation of closure of trading window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed the stock exchanges that its trading window will be closed from October 1, 2025, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter and half year ended September 30, 2025. This is a standard compliance step taken ahead of the Q2 and H1 FY26 results announcement. The company has not yet disclosed the date of the board meeting where these results will be considered, and will communicate it separately later.
This is a routine regulatory filing with no direct impact on the stock price. However, it signals that the Q2/H1 FY26 results announcement is approaching, which may attract investor attention once the date is confirmed.